The completion of the $3.0 million common share repurchase program demonstrates Pyxis Tankers' commitment to returning value to shareholders and potentially enhancing share price. Redemption of ...
Pyxis Lamda SPP / S. Korea MR2 50,145 2017 Spot n/a n/a Pyxis Theta (2) SPP / S. Korea MR2 51,795 2013 Time $ 22,000 Dec 2025 Pyxis Karteria (3) Hyundai / S. Korea MR2 46,652 2013 Time 24,500 Sep ...
Pyxis Oncology announces Phase 1/2 trials for PYX-201, combining it with KEYTRUDA® to treat advanced solid tumors. Pyxis Oncology, Inc. has announced the initiation of two significant clinical ...
Maroussi, Greece – January 30, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback